<DOC>
	<DOC>NCT01524666</DOC>
	<brief_summary>This is a nonblinded Case-only study that evaluates the effects of Agmatine Sulfate on small fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of Arginine) and monitored for two months. Improvement will be noted on their response to the Neuropathic Pain Questionnaire. Additionally the investigators will note improvement by performing autonomic function testing at the beginning and end of the study.</brief_summary>
	<brief_title>Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Erythromelalgia</mesh_term>
	<criteria>Men and Women Ages 1875 with symptoms of small Fiber Neuropathy and have been diagnosed via autonomic function testing and or skin biopsy Women who are pregnant or breast feeding, patients with history of substance abuse, and patients with myelopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>